Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Capricor Therapeutics (CAPR) and Agilent (A).
Capricor Therapeutics (CAPR)
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Capricor Therapeutics today and set a price target of $3.50. The company’s shares closed on Friday at $0.37, close to its 52-week low of $0.31.
Pantginis observed:
“Valuation and potential impediments to achieving it. We maintain our Buy rating though are lowering our price target to $3.50 from $8.60. The factors impacting our price target change include: (1) adjustment to base year (positive impact); (2) adjusting fully diluted share count (negative impact); and (3) increasing our discount rate to 30% from 15%, likely temporarily, to account for the increased risk profile of the company currently based on the partial clinical hold and potential outcomes, as well as increasing financing overhang at the company.”
According to TipRanks.com, Pantginis is ranked 0 out of 5 stars with an average return of -26.7% and a 20.3% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Applied Genetic Technologies, Iovance Biotherapeutics Inc, and Checkpoint Therapeutics Inc.
Capricor Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $3.50.
See today’s analyst top recommended stocks >>
Agilent (A)
Agilent received a Hold rating from Alembic Global analyst Hassan Ahmed today. The company’s shares closed on Friday at $65.96.
Ahmed commented:
“We also highlight several names we believe will underperform in 2019 as negative earnings revisions catch up to recent negative share price performance. Our base case assumes that economic and political uncertainty will persist through 2019, with associated share price volatility.”
According to TipRanks.com, Ahmed is ranked 0 out of 5 stars with an average return of -8.8% and a 35.3% success rate. Ahmed covers the Consumer Goods sector, focusing on stocks such as Westlake Chemical Corp, Venator Materials Plc, and LyondellBasell.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Agilent with a $84.50 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
